857 completed, 239 unknown, 126 recruiting, 110 terminated. 1510 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 1510 | Completed 857, Unknown 239, Recruiting 126, Terminated 110, Not yet recruiting 76, Withdrawn 58, Active not recruiting 33, Enrolling by invitation 11 |
Follow Skin Diseases: new trials by email Literature Review of Skin Diseases trials Research Report on Skin Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients Skin Cleanser Combination No.1 - Atopic Dermatitis | Phase 4 | Not yet recruiting | Boston Children's Hospital | 100 | 2031-01-01 | 2026-03-10 |
| Suzetrigine Versus Standard Analgesia After Skin Cancer Surgery Suzetrigine, Acetaminophen Plus Ibuprofen - Postoperative Pain, Acute Pain | Phase 4 | Not yet recruiting | University of Minnesota | 230 | 2027-04-01 | 2026-09-25 |
| Evaluation of the Efficacy and Acceptability of a Phytotherapy Combining Devil's Claw, Blackcurrant and Meadowsweet for the Management of Aromatase Inhibitor-induced Arthralgia in Patients Treated for Localized Breast Cancer in the Adjuvant Setting Phytotherapy Dietary Supplement (Harpagophytum, Meadowsweet, and Blackcurrant), Patient Experience Questionnaire - Hormone Therapy-induced Arthralgia, Phytotherapy | Phase 4 | Not yet recruiting | Hospices Civils de Lyon | 105 | 2027-01-01 | 2026-11-03 |
| Opzelura Experience Study ruxolitinib, ruxolitinib and an Eczema Action Plan - Atopic Dermatitis | Phase 4 | Not yet recruiting | Wake Forest University Health Sciences | 50 | 2026-12-01 | 2026-09-04 |
| Comparative Efficacy of Luliconazole and Bifonazole Combined With Itraconazole in Dermatophytosis Itraconazole, Luliconazole Cream 1%, Bifonazole cream 1% - Tinea Corporis, Tinea Cruris | Phase 4 | Not yet recruiting | University of Faisalabad | 182 | 2026-12-01 | 2026-11-12 |
| A Study to Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Unresectable or Metastatic Melanoma Participants In India Nivolumab + Relatlimab - Unresectable Melanoma, Metastatic Melanoma | Phase 4 | Not yet recruiting | Bristol-Myers Squibb | 40 | 2026-11-15 | 2026-08-12 |
| AD Treatment Optimization With Ebglyss in Real-World Practice: A Multicenter Study of Patient-Centered Outcomes Lebrikizumab-lbkz - Atopic Dermatitis | Phase 4 | Not yet recruiting | Forefront Dermatology S.C | 250 | 2026-11-11 | 2026-10-02 |
| Baseline Dermoscopic Vascular Score and Response to Oral Tranexamic Acid in Facial Melasma Tranexamic acid, Standardised sunscreen and emollient - Melasma | Phase 4 | Not yet recruiting | Allied Hospital Faisalabad | 128 | 2026-11-01 | 2026-10-19 |
| Clascoterone Versus Clindamycin Added to Adapalene/Benzoyl Peroxide for Moderate Facial Acne Clascoterone 1% cream, Clindamycin 1% lotion, Adapalene 0.1%/benzoyl peroxide 2.5% gel - Acne Vulgaris | Phase 4 | Not yet recruiting | Allied Hospital Faisalabad | 118 | 2026-11-01 | 2026-10-19 |
| Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds Non-conforming pz-cel surgical application to RDEB wounds, Additional biopsies, Pz-cel surgical application to DEB wounds - Epidermolysis Bullosa (EB), Recessive Dystrophic Epidermolysis Bullosa (RDEB) | Phase 4 | Not yet recruiting | Abeona Therapeutics, Inc | 100 | 2026-11-01 | 2026-08-06 |
| Emerging Indications for Hyperbaric Oxygen Treatment Hyperbaric oxygen treatment (HBOT), 100% Oxygen - Post-COVID-19 Condition, Ulcerative Colitis | Phase 4 | Not yet recruiting | Jay C. Buckey Jr. | 100 | 2026-11-01 | 2026-09-09 |
| FES PET/MRI for Occult Disease in Lobular Breast Cancer 18Fluoroestradiol (18F-FES), MRI, Gadolinium-based contrast agent (GBCA) - Lobular Breast Carcinoma | Phase 4 | Recruiting | University of Wisconsin, Madison | 30 | 2026-11-01 | 2026-11-10 |
| A Study to Investigate Dupixent/ Dupilumab in Adult Indian Participants With Moderate-to-severe Atopic Dermatitis Dupilumab - Atopic Dermatitis | Phase 4 | Not yet recruiting | Sanofi | 56 | 2026-10-28 | 2026-10-29 |
| Clinical Evaluation of an Oil-Balancing Facial Sunscreen With Topical Tretinoin oil-balancing sunscreen - Acne | Phase 4 | Enrolling by invitation | Colgate Palmolive | 40 | 2026-10-28 | 2026-11-12 |
| Microneedling-Assisted Metformin, Tranexamic Acid, and Modified Kligman's Formula for Melasma Metformin 30% Topical Lotion, Tranexamic Acid 0.5% Topical Solution, Modified Kligman's Formula - Melasma (Facial Melasma) | Phase 4 | Enrolling by invitation | Sameh Sarsik | 80 | 2026-10-25 | 2026-10-27 |
| Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia Lower-Extremity Revascularization, Donaperminogene Seltoplasmid - Chronic Limb-Threatening Ischemia, Diabetic Foot Ulcer | Phase 4 | Not yet recruiting | First Affiliated Hospital of Wenzhou Medical University | 180 | 2026-10-20 | 2026-09-18 |
| Efficacy and Safety of Triple-Combination Cream Plus Microneedling Along With Tranexamic Acid Versus Platelet-Rich Plasma in the Treatment of Moderate-to-Severe Melasma: A Randomized Comparative Study Group B (Triple Combination Cream + Microneedling + Platelet-Rich Plasma) - Melasma (Facial Melasma) | Phase 4 | Active not recruiting | Bangladesh Medical University | 60 | 2026-10-13 | 2026-10-23 |
| Bimzelx (Bimekizumab) For The Treatment Of Adult Onset Pityriasis Rubra Pilaris (PRP) Bimekizumab - Pityriasis Rubra Pilaris | Phase 4 | Not yet recruiting | Mayo Clinic | 12 | 2026-10-01 | 2026-09-08 |
| A Study of QL1706 Combined With OH2 Injection in Perioperative Treatment of Stage III Resectable Acral Melanoma Iparomlimab and Tuvonralimab Injection (QL1706), OH2 Injection(Recombinant Human GM-CSF Oncolytic Type II Herpes Simplex Virus) - Melanoma, Acral Melanoma | Phase 4 | Not yet recruiting | Peking University Cancer Hospital & Institute | 76 | 2026-10-01 | 2026-10-02 |
| Comparison of Itraconazole With Itraconazole and Isotretinoin in the Treatment Duration, Safety a n d Cure Rate in Adult Patients of Tinea Corporis/ Cruris-A Randomised Controlled Trail Itraconazole (200 mg), ISOtretinoin 20 MG - Tinea Corporis | Phase 4 | Not yet recruiting | Pak Emirates Military Hospital | 60 | 2026-10-01 | 2026-06-30 |
Showing 20 of 1510. Sign in to see all of them.
Breast Neoplasms (280) · Psoriasis (184) · Dermatitis, Atopic (136) · Acne Vulgaris (122) · Diabetic Foot (55) · Arthritis, Psoriatic (48) · Keratosis, Actinic (46) · Pruritus (33) · Eczema (29) · Melanoma (27) · Rosacea (27) · Melanosis (26) · Alopecia Areata (25) · HIV Infections (24)
Skin and Connective Tissue Diseases (1509) · Neoplasms (376) · Neoplasms by Site (325) · Breast Diseases (289) · Immune System Diseases (281) · Skin Diseases, Papulosquamous (250) · Pathological Conditions, Signs and Symptoms (240) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (188) · Hypersensitivity (187) · Genetic Diseases, Inborn (178) · Hypersensitivity, Immediate (177) · Cardiovascular Diseases (167) · Dermatitis (166) · Skin Diseases, Eczematous (165)
Methotrexate (32) · Gels (30) · Etanercept (29) · dupilumab (29) · Adalimumab (26) · Adapalene (26) · Benzoyl Peroxide (23) · Standard of Care (23) · Sodium Chloride (22) · apremilast (22) · pimecrolimus (22) · secukinumab (22) · Doxycycline (21) · Triamcinolone Acetonide (21) · Letrozole (20)
Galderma R&D (39) · Novartis Pharmaceuticals (28) · Assiut University (27) · Stiefel, a GSK Company (21) · Ottawa Hospital Research Institute (18) · Cairo University (17) · Novartis (17) · University of California, San Francisco (17) · Hoffmann-La Roche (14) · Allergan (13) · Psoriasis Treatment Center of Central New Jersey (13) · Amgen (12) · Bausch Health Americas, Inc. (12) · Mahidol University (12) · Pfizer (12)
United States (571) · China (111) · Germany (92) · Canada (85) · France (75) · Spain (65) · United Kingdom (58) · Italy (57) · Egypt (56) · Netherlands (52) · Denmark (42) · Belgium (40) · India (37) · Brazil (35) · South Korea (32)
Ronald W Gottschalk, MD (9) · Robert Bissonnette, MD (8) · Herbert B Slade, MD (7) · Leon H. Kircik, M.D. (6)
PMID 38979716, PMID 19935134, PMID 22882561, PMID 25913550, PMID 26982791, PMID 28924971, PMID 29951993, PMID 30415588, PMID 15389191, PMID 20684151, PMID 25071111, PMID 25153486, PMID 26348120, PMID 26438146, PMID 27432417, PMID 28532759, PMID 29448838, PMID 29776990, PMID 30243803, PMID 33283264, PMID 34061144, PMID 42694939, PMID 42825996, PMID 10233295, PMID 1052771, PMID 10536559, PMID 10607349, PMID 10642676, PMID 10865927, PMID 10951254, PMID 11050519, PMID 11063900, PMID 11096382, PMID 11256129, PMID 11453873, PMID 11463434, PMID 11488820, PMID 11855913, PMID 11966728, PMID 12095065, PMID 12127688, PMID 12243706, PMID 12457622, PMID 12533168, PMID 12553848, PMID 12810507, PMID 12839559, PMID 12893742, PMID 13519856, PMID 13571547
2015 (9), 2008 (8), 2018 (8), 2016 (7), 2023 (7), 2004 (5), 2025 (5), 2014 (4), 2019 (4), 2005 (3), 2009 (3), 2017 (2), K23AI070078 (1), K23AR080043 (1), K23DK079789 (1)